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Background: Polycystic ovary syndrome (PCOS) is a common female endocrine
condition of unclear etiology characterized by hyperandrogenism, oligo/amenorrhoea,
and polycystic ovarian morphology. PCOS is often complicated by infertility,
overweight/obesity, insulin resistance, and low-grade inflammation. The gut microbiome
is known to contribute to several of these conditions. Recently, an association between
stool and saliva microbiome community profiles was shown, making saliva a possible
convenient, non-invasive sample type for detecting gut microbiome changes in systemic
disease. In this study, we describe the saliva microbiome of PCOS patients and the
association of microbiome features with PCOS-related parameters.
Methods: 16S rRNA gene amplicon sequencing was performed on saliva samples from
24 PCOS patients and 20 healthy controls. Data processing and microbiome analyses
were conducted in mothur and QIIME. All study subjects were characterized regarding
reproductive, metabolic, and inflammatory parameters.
Results: PCOS patients showed a decrease in bacteria from the phylum Actinobacteria
and a borderline significant shift in bacterial community composition in unweighted
UniFrac analysis. No differences between patients and controls were found in alpha
diversity, weighted UniFrac analysis, or on other taxonomic levels. We found no
association of saliva alpha diversity, beta diversity, or taxonomic composition with serum
testosterone, oligo/amenorrhoea, overweight, insulin resistance, inflammatory markers,
age, or diet.
Conclusions: In this pilot study, patients with PCOS showed a reduced salivary relative
abundance of Actinobacteria. Reproductive and metabolic components of the syndrome
were not associated with saliva microbiome parameters, indicating that the majority of
between-subject variation in saliva microbiome profiles remains to be explained.
Keywords: polycystic ovary syndrome, sex steroids, human oral microbiome, next-generation sequencing, 16S
rRNA, obesity, inflammation
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is a common female
endocrine condition affecting 6–18% of reproductive-age women
and comprising the three primary symptoms hyperandrogenism,
oligo/amenorrhoea, and polycystic ovarian morphology
(Diamanti-Kandarakis et al., 1999; Asuncion et al., 2000; Azziz
et al., 2004; March et al., 2010). In addition to reduced fertility,
pregnancy complications, and cosmetic problems, women with
PCOS are at risk to develop disorders of glucose and lipid
metabolism, chronic low-grade inflammation, and the associated
long-term complications (Barry et al., 2011; Escobar-Morreale
et al., 2011; Lerchbaum et al., 2011, 2013; Wehr et al., 2011;
Dumesic et al., 2015; Kollmann et al., 2015). Different criteria
for the diagnosis of PCOS exist, leading to a wide variety
of phenotypes ranging from mild to severe. Currently, the
Endocrine Society recommends the use of the Rotterdam
Criteria for the diagnosis of PCOS (Legro et al., 2013).
The etiology of PCOS is still unclear, although a multifactorial
pathogenesis including genetic, lifestyle, and intrauterine factors
has been suggested (Dumesic et al., 2015). Recent research
in rodents and humans has implicated the gut microbiome
in the pathogenesis of numerous diseases, including obesity,
insulin resistance, and type 2 diabetes (Bäckhed et al., 2004;
Turnbaugh et al., 2006, 2009; Vrieze et al., 2012). The majority
of gut microbiome studies have investigated the distal digestive
tract (e.g., fecal or cecal samples); however, cooling, transport,
and DNA extraction methods from these sample types are
non-standardized and known to cause substantial variation in
sequencing results (Goodrich et al., 2014).
We have investigated the microbiome of the proximal
digestive tract as a possible indicator of disease in PCOS. Saliva
offers several advantages over stool as a sample material for
microbiome studies. These are the non-invasive on-site collection
with little or no discomfort to the patient, the possibility for
immediate processing and/or freezing following collection to
conserve bacterial community structures, and the use of defined,
reproducible sample volumes for DNA extraction. It has recently
been shown that saliva microbiome profiles correlate with those
in the stool, despite the fact that the bacterial communities in the
two locations differ greatly (Ding and Schloss, 2014). Therefore,
saliva may be a useful alternative to stool as an indicator of
bacterial dysbiosis in systemic disease.
To our knowledge, there are no published studies of either
the fecal or saliva microbiome in patients with PCOS using
a next-generation sequencing approach. PCOS patients exhibit
an increased prevalence of gingivitis, which was found to be
accompanied by changes in certain oral bacterial species, assessed
by qPCR (Akcali et al., 2014). However, data on the global saliva
microbiome in periodontally healthy PCOS patients compared to
control women is lacking.
We performed a pilot study to describe the salivary
microbiome in PCOS and to investigate the potential of specific
taxa and measures of bacterial diversity to distinguish between
women with PCOS and healthy women. Additionally, we
investigated the association of diagnostic (serum testosterone,
oligo/amenorrhoea) and common co-occurring (overweight,
insulin resistance, inflammation) features of PCOS with saliva
microbiome parameters. Finally, we addressed the role of age
and diet as possible confounding factors in saliva microbiome
studies.
MATERIALS AND METHODS
Study Cohort
Twenty-five women with PCOS and 25 hormonally healthy
controls were recruited from the endocrinological outpatient
clinic at the University Hospital Graz. PCOS was diagnosed
according to the Rotterdam Criteria, requiring the presence of
two out of three of the following criteria: clinical/biochemical
hyperandrogenism, oligo-/anovulation, and polycystic ovaries
(Rotterdam ESHRE/ASRM-Sponsored PCOS consensus
Workshop Group, 2004). Clinical hyperandrogenism, based
on the presence of hirsutism, was defined as a score of eight
or higher in the modified Ferriman-Gallwey (FG) assessment
(Yildiz et al., 2010). Biochemical hyperandrogenism was
defined as above-normal values of one or several serum
androgens. Oligo-/anovulation was defined as prolonged
menstrual cycles (>35 days) or the absence of menstruation
for at least 3 months. Polycystic ovarian morphology in a
gynecological ultrasound was assessed based on medical history.
Thyroid disorder, congenital adrenal hyperplasia, Cushing’s
syndrome, hyperprolactinemia, androgen-secreting tumors,
and pregnancy were excluded by appropriate laboratory
tests and clinical examination. Healthy controls did not
meet any of the Rotterdam Criteria, with the following
exceptions: isolated elevation of dehydroepiandrosterone
sulfate (DHEAS) or androstenedione without other signs
of PCOS (6 subjects) and long-standing hirsutism without
hyperandrogenemia (1 subject). Exclusion criteria for both
groups were pregnancy/lactation, menopause, use of antibiotics,
hormonal contraceptives, or antidiabetic medication within the
preceding 3 months, gastrointestinal or periodontal disease,
active infections of any kind, a body mass index (BMI) <18,
and smoking. All study participants were at least 18 years old
and provided written informed consent. The study protocol was
approved by the Ethics Committee at the Medical University
Graz.
Sampling
Study visits took place in the morning after an overnight fast.
Study subjects were instructed not to brush their teeth and to
drink only water prior to saliva sampling. Saliva was collected
in the mouth for several minutes and then voided into Sali-
Tubes (DRG Diagnostics, Marburg, Germany). This process was
repeated until the desired volume of 1–2ml was reached. Saliva
samples were immediately cooled on ice, flash-frozen in liquid
nitrogen, and stored at−70◦C until further processing.
Anthropometric data were recorded and a baseline hormonal
and metabolic assessment performed. Following the baseline
blood sampling, a 2-h, 75 g oral glucose tolerance test (oGTT;
Glucoral 75 Citron, Germania Pharmazeutika, Vienna, Austria)
was performed and glucose and insulin were measured after 30,
60, and 120min.
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Laboratory Measurements
Estrone (E1), 17-estradiol (E2), total testosterone,
androstenedione, dehydroepiandrosterone (DHEA), DHEAS,
and dihydrotestosterone (DHT) were measured by liquid
chromatography-tandem mass spectrometry at the Department
of Clinical Chemistry at the University Hospital of South
Manchester, Manchester, United Kingdom, as described by
Keevil et al. (Chadwick et al., 2005; Owen et al., 2014, 2015;
Münzker et al., 2015).
Insulin was measured by chemiluminescence immunoassay
on the ADVIA Centaur XP (Roche, Rotkreuz, Switzerland).
Anti-Muellerian hormone (AMH) was measured by
chemiluminescence immunoassay on the Access2 (Beckman
Coulter, Brea, USA). Luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) were measured by ELISA (both
DiaSource, Louvain-la-Neuve, Belgium). Sex hormone-binding
globulin (SHBG) was measured by chemiluminescence
immunoassay on the Cobas e411 (Roche). Total cholesterol,
high-density lipoprotein-cholesterol (HDL), triglycerides, and
glucose were measured by enzymatic colorimetric assay on the
Cobas c module (Roche). Serum high-sensitivity C-reactive
protein (hs-CRP) was measured by ELISA (BioVendor, Brno,
Czech Republic). A total and differential blood count was
performed on the XE-5000 Hematology Analyzer (Sysmex,
Vienna, Austria).
Calculations and Definition of Terms
BMI was calculated as Weight (kg)
(Height (m))2
. Overweight was defined as
a BMI ≥ 25. The homeostasis model assessment for insulin
resistance (HOMA2-IR) index was calculated using the open-
source software HOMA calculator V2.2.3 provided by the
Diabetes Trial Unit, University of Oxford, UK (www.dtu.ox.
ac.uk/homacalculator/, last accessed Dec 17, 2015). Insulin
resistance was defined as a HOMA2-IR ≥ 2. The area under the
curve (AUC) for glucose and insulin was calculated from the
oGTT using the trapezoidal method in GraphPad Prism 5. Free
androgen index (FAI) was calculated according to the formula
100× Total testosterone (nmol/l)SHBG (nmol/l) . Free testosterone and free DHTwere
calculated from total testosterone/DHT and SHBG according
to Mazer et al. assuming a blood albumin concentration of
6.2µmol/l (Mazer, 2009).
A food frequency questionnaire designed by dieticians of the
Clinical Medical Nutrition Therapy Unit, University Clinic Graz,
was administered to assess the intake of major food groups.
Based on the results of the questionnaire, study participants were
categorized as consuming a high carbohydrate or high animal
protein diet.
Next-Generation Sequencing
Total DNA was extracted from saliva samples using the
MagNAPure LC DNA Isolation Kit III (Bacteria, Fungi) on the
MagNA Pure Instrument (Roche, Rotkreuz, Switzerland). Saliva
was thawed, vortexed, and 250µl saliva was added to 250µl
bacteria lysis buffer in a sample tube containing MagNALyser
Green Beads (1.4mm diameter ceramic beads, Roche). Samples
were homogenized in a MagNALyser Instrument (2 × 6000
rpm for 30 s, separated by 1min cooling), treated with 25µl
lysozyme (Roth, Karlsruhe, Germany) at 37◦C for 30min,
and then with 43.3µl proteinase K (Roche) at 60◦C for 1 h.
Lysates were incubated at 95◦C for 10min, cooled on ice
for 5min, and centrifuged for 5min at full speed. DNA was
isolated from 200µl lysate supernatant by the MagNAPure
Instrument using the manufacturer’s software and eluted in
100µl elution buffer. A PCR reaction was performed to
amplify the V1-2 region of the bacterial 16S rRNA gene
using the primers F27 (AGAGTTTGATCCTGGCTCAG) and
R357 (CTGCTGCCTYCCGTA; Eurofins Genomics, Ebersberg,
Germany) and the FastStart High Fidelity PCR System, dNTPack
(Roche) with initial denaturation at 95◦C for 3min followed
by 28 cycles of denaturation at 95◦C for 45 s, annealing at
55◦C for 45 s, and extension at 72◦C for 1min, one cycle of
final extension at 72◦C for 7min, and a final cooling step to
10◦C. Triplicates were pooled, checked on a 1% agarose gel,
and 15µl of pooled PCR product were normalized according
to manufacturer’s instructions on a SequalPrep Normalization
Plate (Life Technologies, Vienna, Austria). Fifteen microliters of
the normalized PCR product were used as template for indexing
PCR in a 50µl single reaction to introduce barcode sequences to
each sample according to Kozich et al. (2013). Cycling conditions
were initial denaturation at 95◦C for 3min followed by eight
cycles of denaturation at 95◦C for 45 s, annealing at 55◦C for 45 s,
and extension at 72◦C for 1min, one cycle of final extension at
72◦C for 7min, and a final cooling step to 4◦C. After indexing,
5µl of each sample were pooled and 50µl of the unpurified
library were loaded on a 1% agarose gel and purified from
the gel with the Qiaquick Gel Extraction Kit (Qiagen, Hilden,
Germany) according to manufacturer’s instructions. The pool
was quantified using QuantiFluor ONE dsDNA dye on a Quantus
Fluorometer (Promega, Mannheim, Germany) according to
manufacturer’s instructions and visualized for size validation
on a 2100 Bioanalyzer Instrument (Agilent Technologies, Santa
Clara, USA) using a high sensitivity DNA assay according to
manufacturer’s instructions. The final 6 pM library containing
all pooled samples was run with 20% PhiX and version 3, 600
cycles chemistry according to manufacturer’s instructions on a
MiSeq desktop sequencer (Illumina, Eindhoven, Netherlands).
One negative control (250µl sterile PBS instead of saliva) was
included in each MagNAPure run and subjected to the same
procedures as samples. A mock community containing genomic
DNA from 20 bacterial species was included to estimate PCR and
sequencing errors (HM-782D, BEI Resources, Manassas, USA).
Sequencing Data Analysis
Raw reads were processed using the open-source software
mothur V1.35.0 according to the protocol by Kozich et al.
(April 2015), with the following adaptations: no maxlength
was defined during the screening step, start (1046) and end
(6426) positions were adapted to the V1-V2 region, and a
difference of 3 bases was permitted during the precluster step
(based on the recommendation by the authors to allow one
mismatch per 100 bp; Kozich et al., 2013). Chimeric sequences
were removed by UCHIME (Edgar et al., 2011). After removal of
non-bacterial sequences, classified using the SILVA119 database
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(www.arb-silva.de), the remaining sequences were degapped,
deuniqued, split into individual samples, and formatted for
use with the open-source software QIIME 1.8.0 (Caporaso
et al., 2010). Open reference operational taxonomic unit (OTU)
picking was performed in QIIME using UCLUST against the
Greengenes 13.8 database (DeSantis et al., 2006). An OTU was
defined as a group of sequences with a similarity of 97% or more.
Based on the mock community sequencing results, a relative
abundance cutoff of 0.1% was applied for subsequent analyses.
Faith’s phylogenetic diversity and the number of observed OTUs
were used as metrics for alpha rarefaction, which was performed
in QIIME. Principal coordinate analyses (PCoA) were based
on unweighted and weighted UniFrac distances and calculated
in QIIME (Lozupone and Knight, 2005). Taxa summaries were
performed in QIIME. All samples were normalized to the
sample with the lowest read count for alpha and beta diversity
comparisons. For taxa comparisons, relative abundances based
on all obtained reads were used.
Raw sequencing data are available in NCBI’s short read archive
(SRA) under the accession number SRP077213.
Statistical Analysis
Nonparametric student’s t-tests using Monte Carlo permutations
were used for alpha diversity comparisons, Mann–Whitney
U-tests for taxa comparisons, and Adonis for category
comparisons of distance matrices, all calculated in QIIME.
Benjamini–Hochberg false discovery rate (FDR) correction was
used to correct for multiple hypothesis testing where applicable.
All remaining statistical calculations were performed in
IBM SPSS Statistics Version 22. Depending on the statistical
distribution of the variable, unpaired t-tests or Mann–Whitney
U-tests were used to compare groups. Fisher’s Exact tests were
used to compare categorical parameters. All data are expressed as
median and interquartile range (IQR).
RESULTS
Study Subject Characteristics
All 50 subjects included in the study provided saliva samples.
Three subjects were excluded from the control group due to
previously undetected hyperandrogenemia (elevation of two or
more androgens in fasted blood sample), two subjects were
excluded due to smoking prior to sampling, and one subject was
excluded due to a BMI < 18. The final analyses were performed
with 20 healthy controls and 24 PCOS patients.
Laboratory, anthropometric, and patient history data are
summarized in Table 1. Patients with PCOS had significantly
higher total testosterone, androstenedione, and DHEA (p =
0.002, <0.001, and 0.015, respectively) and lower E2 (p < 0.001)
levels than healthy controls, while no difference was found for
DHEAS, DHT, and E1 (p = 0.073, 0.096, and 0.138, respectively).
Calculated free DHT, free testosterone, and FAI were higher in
the PCOS group (p < 0.001 for all). PCOS patients showed
a characteristic dysregulation of FSH and LH secretion, with
increased LH levels compared to controls (p = 0.035). Hirsutism
and oligo/anmenorrhoea were more prevalent in the PCOS
group (p = 0.003 and <0.001, respectively). Nearly all PCOS
patients reported a history of polycystic ovaries (p < 0.001),
which was corroborated by elevated AMH levels at the time
of sampling (p < 0.001). An increased basal insulin secretion
and AUCinsulin in the oGTT, elevated total triglycerides, and
reduced HDL-cholesterol were observed in the PCOS group (p =
0.022, 0.009, 0.010, and 0.006, respectively). The studied cohort
included lean as well as obese PCOS patients. Overall, BMI did
not differ between PCOS patients and controls (p = 0.147).
Total blood leukocytes were significantly higher in PCOS patients
compared to healthy controls (p = 0.040), while hsCRP was not
significantly different between the two groups (p = 0.078).
Assessment of Sequencing Error and Bias
Using a Mock Community
A mock community containing genomic DNA from twenty
bacterial species, representing 17 genera, was included in the
16S rRNA PCR and sequencing to estimate OTU inflation and
classification bias due to sequencing errors. After removal of
singleton OTUs, we detected 214 OTUs from 29 genera in
the mock community sample, indicating an overestimation of
the number of OTUs due to sequencing errors (Table 2). After
filtering themock community and our dataset to 1, 0.1, and 0.01%
relative abundance, we determined that a cutoff of 0.1% best
represented the mock community, detecting 31 OTUs from 19
genera (Supplementary Data Sheet 1). We therefore performed
the subsequent analysis using this abundance filter.
Using the 0.1% cutoff, all bacteria in the mock
community were correctly classified at the family level,
15/17 at the genus level, and 7/20 at the species level
(Supplementary Data Sheet 1). The observed relative
abundance of most genera was within 50% of the expected
value (Table 2). Bacteria from the genera Bacteroides and
Helicobacter were more than two-fold overestimated, while
bacteria from the family Gammaproteobacteria were more than
two-fold underestimated (Table 2).
The Saliva Microbiome Composition in
PCOS and Its Association with Metabolic
Dysfunction and Inflammation
16S rRNA amplicon-based microbiome analysis was performed
on saliva samples from 20 healthy controls and 24 PCOS patients,
using an OTU relative abundance cutoff of 0.1%. A median of
80,555 (IQR 18,509) and 72,284 (IQR 20,330) paired-end
Illumina reads were analyzed per sample in the control and
PCOS groups, respectively (p = 0.131). A total number of 131
OTUs [median(IQR) = 119.5(9.0) for controls and 116(8.5) for
PCOS] from 35 genera [median(IQR) = 33(1.0) for controls
and PCOS] were identified. As PCOS is often accompanied by
overweight/obesity, insulin resistance, and chronic low-grade
inflammation, we investigated the association of these features
with saliva microbiome profiles. In addition, we performed
analysis with samples grouped by diet and age, as these factors
have been shown to influence gut microbiome composition
(33–35).
The saliva microbiome was dominated by bacteria from the
phylum Bacteroidetes (median relative abundance 45%) and
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TABLE 1 | Study subject characteristics.
Reference Range Control (n = 20) PCOS (n = 24)
Median IQR Median IQR p-value
Age 32 12.0 27 5.9 0.003**
Body mass index 18.5–25.0# 22.3 4.10 24.9 11.75 0.147
Waist to hip ratio <0.85# 0.80 0.063 0.82 0.077 0.439
Fasting glucose (mmol/l) <7.0† 4.5 0.50 4.7 0.59 0.209
2h glucose (mmol/l) <11.1† 4.3 1.09 4.8 1.15 0.296
AUC glucose (mmolh/l) § 10.2 4.52 10.9 3.61 0.273
Fasting insulin (pmol/l) 20.9–173.8 41.4 51.08 84.4 55.25 0.022*
2h insulin (pmol/l) § 129 140.0 188 336.7 0.371
AUC insulin (mmolh/l) § 353 427.3 691 562.0 0.009**
HOMA2-IR <2 0.8 1.05 1.7 1.20 0.027*
Total cholesterol (mmol/l) <5.2 4.6 0.64 4.5 1.13 0.699
HDL-cholesterol (mmol/l) >1.0 2.0 0.42 1.7 0.49 0.006**
Triglycerides (mmol/l) <1.65 0.59 0.248 0.74 0.242 0.010*
Follicle-stimulating hormone (IU/l) 0.5–61.2‡ 9.2 8.11 7.5 2.73 0.178
Luteinizing hormone (IU/l) 2.0–22.0‡ 5.8 9.34 9.3 8.60 0.042*
LH:FSH ratio § 1.2 1.19 1.5 1.06 0.035*
Anti-Muellerian hormone (pmol/l) 1.4–65.2 26.8 22.42 61.1 52.59 <0.001***
Total testosterone (nmol/l) 0.37–2.12 1.1 0.56 1.3 0.77 0.002**
Dihydrotestosterone (nmol/l) § 0.34 0.241 0.46 0.528 0.096
Androstenedione (nmol/l) 0.89–7.46 2.6 1.61 4.2 2.69 <0.001***
Dehydroepiandrosterone (nmol/l) § 13.7 11.37 21.4 12.40 0.015*
Dehydroepiandrosterone sulfate (µmol/l) § 3.3 3.74 4.9 2.35 0.073
Estrone (pmol/l) § 274 184.8 195 118.9 0.138
17-Estradiol (pmol/l) § 436 285.8 163 181.1 <0.001***
Free androgen index § 1.3 0.68 3.1 2.75 <0.001***
Free testosterone (pmol/l) § 10.6 5.86 20.9 13.00 <0.001***
Free dihydrotestosterone (pmol/l) § 1.3 1.03 3.0 2.19 <0.001***
Total blood leukocytes (G/l) 4.4–11.3 4.7 1.47 5.5 1.78 0.040*
hsCRP (mg/l) § 0.5 0.70 0.8 3.97 0.078
# of cases % of cases # of cases % of cases p-value
Polycystic ovarian morphology 0 0 22 96 <0.001***
Hirsutism 1 5 11 46 0.003**
Oligo-/Amenorrhoea 1 5 17 71 <0.001***
High carbohydrate diet 8 40 9 38 0.555
High animal protein diet 12 60 15 63 0.555
PCOS, polycystic ovary syndrome; IQR, interquartile range; AUC, area under the curve; HOMA2-IR, homeostasis model assessment for insulin resistance; HDL, high density lipoprotein;
hsCRP, high-sensitivity C-reactive protein. Groups were compared using unpaired t-tests, Mann–Whitney U-tests, and Fisher’s Exact tests. #according to the World Health Organization,
†
according to the American Diabetes Association,
‡
depending on menstrual cycle stage, §reference range not available. *p < 0.05, **p < 0.01, ***p < 0.001.
Firmicutes (26%), while bacteria from the phyla Proteobacteria,
Fusobacteria, Actinobacteria, and TM7 contributed <10% each
to total bacterial content (Table 3). On genus level, Prevotella
was the single most abundant genus (median relative abundance
31%), followed by Streptococcus (11%), with other genera
contributing <10% each to total bacterial content (Table 3).
Saliva samples from PCOS patients showed a significant
decrease in the relative abundance of bacteria from the phylum
Actinobacteria (FDR p = 0.024). On class, order, family, genus,
and OTU level, no differences were observed between patients
and controls (Table 3, Supplementary Data Sheet 2).
The cumulative curve of observed genus level abundances
followed a long-tailed distribution, with the ten most abundant
genera accounting for 86% of all identified bacteria (Figure 1).
Faith’s phylogenetic diversity and the number of observed
OTUs did not differ between PCOS patients and controls
(Figure 2). Additionally, serum testosterone and the presence
of oligo-/amenorrhoea were not associated with a change
in these parameters (Figure 3). Alpha diversity curves
of individual samples showed excellent saturation both
unrarefied and at the selected rarefaction level of 45,949 reads
(Supplementary Image 1).
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TABLE 2 | Expected and observed relative abundances of bacterial genera
in a mock community.
Genus Expected RA Observed RA Fold 1
#Acinetobacter 0.05 0.02 −2.4
†Actinomyces 0.05 0.03 −1.6
‡Bacillus 0.05 0.04 −1.2
§Bacteroides 0.05 0.12 2.4
‡Clostridiaceae unclass 0.05 0.06 1.2
||Deinococcus 0.05 0.04 −1.2
‡Enterococcaceae unclass 0.05 0.04 −1.4
#Enterobacteriaceae unclass 0.05 0.02 −2.2
#Helicobacter 0.05 0.11 2.2
‡Lactobacillus 0.05 0.06 1.3
‡Listeria 0.05 0.05 1.0
#Neisseria 0.05 0.06 1.3
†Proprionibacterium 0.05 0.06 1.1
#Pseudomonas 0.05 0.02 −2.7
#Rhodobacter 0.05 0.04 −1.2
‡Staphylococcus (2 spp.) 0.10 0.09 −1.2
‡Streptococcus (3 spp.) 0.15 0.13 −1.1
Only sequences with a relative abundance >0.1% were included in the analysis.
#Proteobacteria,
†
Actinobacteria,
‡
Firmicutes, §Bacteroidetes, || [Thermi]. RA, relative
abundance; unclass., unclassified; spp., species.
In beta diversity analyses, saliva samples showed a tendency
toward a statistically significant clustering in unweighted
UniFrac analysis (Figure 2D, p = 0.050). No clustering was
observed when comparing weighted UniFrac distance matrices
based on PCOS status, serum testosterone, or the presence of
oligo-/amenorrhoea (Figures 2C, 3).
Grouping samples based on overweight, insulin resistance,
hsCRP, blood leukocytes, age, and diet did not affect alpha
diversity, beta diversity, or taxonomic composition (data not
shown).
DISCUSSION
To our knowledge, this is the first study reporting a next-
generation sequencing-based profile of the saliva microbiome
in PCOS patients. The phyla and genera that were found
to dominate saliva microbiome profiles in our study cohort
correspond to those previously reported for healthy adults
(Keijser et al., 2008; De Filippis et al., 2014; Ding and
Schloss, 2014). We show that PCOS is associated with
a decreased relative abundance of salivary Actinobacteria
and a borderline significant clustering of bacterial profiles
in unweighted UniFrac analysis. This observation was not
explained by individual components of the syndrome, namely
hyperandrogenemia and oligo/amenorrhoea, or by associated
features such as overweight, insulin resistance, and low-grade
inflammation.
Actinobacteria, a phylum of gram-positive bacteria, are
common members of the skin and oral microbiota and have
been reported to be reduced in periodontal disease (Liu et al.,
TABLE 3 | Relative abundances of bacterial genera and phyla with a
median relative abundance >1%.
Most abundant
genera (>1%)
% of total
bacteria in
Control (n = 20)
% of total
bacteria in PCOS
(n = 24)
FDR
p-value
Median IQR Median IQR
#Prevotella 32.5 8.63 30.8 4.17 0.981
†Streptococcus 10.3 2.69 12.2 8.29 0.740
†Veillonella 8.4 3.65 8.2 5.42 0.847
#[Prevotella] 7.1 7.67 6.5 5.75 0.740
‡Neisseria 6.9 5.74 5.5 7.63 0.740
§Fusobacterium 3.8 3.44 5.4 4.11 0.749
#Porphyromonas 3.0 5.63 5.5 4.60 0.749
||Rothia 4.5 3.31 2.7 2.33 0.726
‡Haemophilus 3.0 2.06 2.3 1.81 0.910
§Leptotrichia 2.1 4.00 1.5 2.25 0.740
||Actinomyces 2.4 0.93 2.3 1.30 0.749
†Granulicatella 1.5 1.04 1.4 0.83 0.740
||Atopobium 1.0 1.11 0.7 0.61 0.740
†Gemellaceae
unclass
0.9 0.76 0.7 0.69 0.941
‡Campylobacter 0.8 0.50 0.7 0.53 0.749
¶TM7-3 unclass 0.8 0.78 0.6 0.75 0.740
Most abundant
phyla (>1%)
Median IQR Median IQR FDR
P-value
#Bacteroidetes 43.9 6.70 46.4 6.88 0.706
†Firmicutes 24.8 6.21 27.1 7.98 0.706
‡Proteobacteria 9.5 8.94 10.1 8.21 0.706
§Fusobacteria 7.2 4.58 7.3 5.37 0.706
||Actinobacteria 8.2 2.19 6.1 2.82 0.024*
¶TM7 1.3 1.38 1.1 1.11 0.492
Groups were compared using Mann–Whitney U-tests followed by Benjamini-
Hochberg FDR correction. PCOS, polycystic ovary syndrome; IQR, interquartile range.
#Bacteroidetes,
†
Firmicutes,
‡
Proteobacteria, §Fusobacteria, ||Actinobacteria, ¶TM7.
Square brackets indicate a Greengenes suggested taxonomic assignment. *p < 0.05.
2012; Wang et al., 2013). Akcali et al. used quantitative real-
time polymerase chain reaction to show changes in several
bacterial species in women with PCOS and gingivitis compared
to healthy women with gingivitis (Akcali et al., 2014). However,
the authors observed no change between periodontally healthy
women with and without PCOS. As our PCOS patients were
periodontally healthy and we did not observe an association
between the saliva microbiome and markers of inflammation,
we hypothesize that the reduction in the relative abundance of
Actinobacteria within the context of PCOS does not itself cause
disease, but rather provides a more favorable environment for
pathology-associated bacteria, which can result in periodontal
disease in the presence of other permissive factors. This
hypothesis is supported by the fact that the prevalence of
periodontal disease is higher in PCOS patients than in the
general population (Porwal et al., 2014; Rahiminejad et al.,
2015).
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Salivary microbiome profiles of PCOS patients showed
a borderline significant clustering in unweighted UniFrac
analysis, while weighted UniFrac distance matrices and alpha
FIGURE 1 | Cumulative distribution of genus relative abundances in
saliva samples. Thirty-five genera were detected in saliva samples. Eighty-six
percent of all identified bacteria are represented by the 10 most abundant
genera.
diversity metrics were not significantly different to controls.
Several explanations exist for this apparent lack of pronounced
differences. On average, the patients in our study displayed
mild phenotypes of PCOS, in that serum androgens were only
slightly elevated compared to controls, parameters related to
glucose and lipid metabolism were within the normal range
for most patients, and BMI was not significantly different from
controls. We did not specifically recruit only lean or obese
PCOS patients, as we were aiming for a broadly representative
cohort of PCOS phenotypes. Shifts in the saliva microbiome
may parallel the clinical phenotype, becoming more pronounced
in the presence of severe hyperandrogenism and anovulation,
either alone or in combination with obesity and/or manifest type
2 diabetes. Furthermore, the approach of this study provides
only information on the presence of bacterial DNA, but not
on bacterial function. Salivary bacteria may have altered gene
expression patterns either in response or as a contributing factor
to the biochemical changes observed in PCOS.
As it is known that the microbiome can be affected by
many exogenous and endogenous factors (Goodrich et al., 2014),
we addressed these possible confounders by either defining
them as an exclusion criterion (such as smoking, antibiotics
FIGURE 2 | Alpha and beta diversity of saliva samples from PCOS patients and controls. (A,B) Alpha rarefaction curves of Faith’s phylogenetic diversity (A)
and the number of observed OTUs (B). Samples were rarefied to the smallest observed number of reads (45,949). Median and IQR are plotted. (C,D) Principal
coordinate analysis (PCoA) plots of weighted (C) and unweighted (D) UniFrac distances. Each dot represents the bacterial community composition of one individual
saliva sample. Groups were compared using Monte Carlo permutations for alpha diversity and Adonis for beta diversity. PCOS, polycystic ovary syndrome.
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FIGURE 3 | Alpha and beta diversity of saliva samples based on PCOS diagnostic criteria. (A–D) Alpha rarefaction curves of Faith’s phylogenetic diversity
(A,C) and the number of observed OTUs (B,D) grouped by serum testosterone (A,B) and the presence of oligo/amenorrhoea (C,D). Samples were rarefied to the
smallest observed number of reads (45,949). Median and IQR are plotted. (E–H) Principal coordinate analysis (PCoA) plots of weighted (E,G) and unweighted (F,H)
UniFrac distances grouped by serum testosterone (E,F) and the presence of oligo/amenorrhoea (G,H). Each dot represents the bacterial community composition of
one individual saliva sample. Groups were compared using Monte Carlo permutations for alpha diversity and Adonis for beta diversity. PCOS, polycystic ovary
syndrome.
use, and periodontal disease) or by performing separate
analyses for these variables (as for BMI, insulin resistance,
inflammation, diet, and age). We did not find an association
of any of these factors with alpha diversity, beta diversity,
or changes in bacterial relative abundance on any taxonomic
level.
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Recent research has indicated that the effect of microbiome
“confounders” may be less significant than previously assumed.
Studies by De Filippis et al. and Belstrøm et al. have reported
no effect of age and diet on saliva microbiome profiles (Belstrøm
et al., 2014; De Filippis et al., 2014), while another study showed
no effect of gender and BMI (Stahringer et al., 2012). Chen et al.
investigated the effect of race, BMI, alcohol intake, sex, tobacco
use, and age on the stool microbiome and found that each
factor explained <1% of variability in stool microbiome profiles
(Chen et al., 2016). These studies, together with our results,
illustrate the large knowledge gaps that still exist about the factors
shaping the microbiome, currently termed “inter-individual
variation.”
The Illumina approach which we selected is among those with
the highest sequencing depth (Sims et al., 2014). Therefore, we
do not expect a great improvement of taxonomic resolution with
an even higher coverage. This could be achieved by increasing
the length of the sequenced 16S rRNA gene fragment. Short
read lengths are a limitation of Illumina paired-end sequencing.
However, lower sequencing errors compared to pyrosequencing
and IonTorrent led us to prefer this approach over one employing
longer read lengths but lower quality. By including a mock
community containing genomic DNA from twenty bacterial
species in equal concentrations, we were able to assess PCR
and sequencing bias. We found that the relative abundances
of the genera Bacteroides and Helicobacter were overestimated,
while the relative abundance of the family Gammaproteobacteria
was underestimated by our employed sequencing approach. It
should be noted that the bacterial community representation
of saliva samples may deviate from this pattern, as DNA
extraction method is also a known source of bias which
was not assessed by the mock community (Goodrich et al.,
2014).
The main strength of our study is the thorough
characterization of our study cohort, which included an
assessment of ovarian and adrenal androgens, lipid metabolism,
and glucose tolerance. Furthermore, we applied strict exclusion
criteria to ensure that no subjects with an undiagnosed mild
form of PCOS or other hormonal imbalance were included
in the control group and to eliminate factors which may
influence the saliva microbiome, such as smoking, the use
of antibiotics, and periodontal disease. A second strength is
our sampling approach. We collected saliva samples after an
overnight fast, avoiding a disturbance of the oral microbiome
due to brushing teeth or using mouthwash. Samples were
immediately frozen in liquid nitrogen to optimally conserve
the bacterial community structure at the time of sampling.
Finally, we used a mock community to evaluate the quality of
the sequencing methodology and found that a large percentage
of OTUs were most likely the result of sequencing errors. By
removing these OTUs, we greatly improved the validity of
our results. Since we thereby also removed a proportion of
true sequences, we applied several filters at different relative
abundance levels, as well as performing an analysis on unfiltered
data, to attain a balanced interpretation of the bacterial
composition of our samples. The significant result was obtained
only when using the 0.1% filter, therefore it should be interpreted
with caution until it can be replicated in a larger cohort of
patients.
Weaknesses of our study are the small sample size, which
precluded stratification of PCOS subtypes, and the paucity of
extreme phenotypes. However, this pilot study was designed
to represent a spectrum of typical Austrian PCOS phenotypes,
allowing a first glimpse at the saliva microbiome in this common
condition. Future studies should aim to recruit large patient and
control groups and stratify based on different PCOS phenotypes,
either based on Rotterdam vs. NIH diagnostic criteria or as
described by Jamil et al. (Dumesic et al., 2007; Jamil et al.,
2015). The addition of a “positive control,” such as patients with
periodontal disease, would underscore the presence or lack of
differences due to PCOS alone and confirm that our result was
not obtained due to technical shortcomings of the employed
method.
While the saliva microbiome appears to be only minorly
changed in PCOS, the microbiome of other body areas may
play a more significant role in this pathology. Two research
groups have recently shown an alteration in the fecal microbiome
of two different rodent models of PCOS (Guo et al., 2016;
Kelley et al., 2016). Furthermore, bacterial colonization of the
vagina and ovarian follicles was found to affect the outcome
of assisted reproductive treatment in women with infertility
of various etiologies, including PCOS (Pelzer et al., 2011).
Next-generation sequencing of samples from these body sites
in PCOS patients presents an interesting approach for future
studies.
In conclusion, we present a first report of the saliva
microbiome composition in PCOS. In our cohort, PCOS patients
showed a reduced relative abundance of bacteria from the
Actinobacteria phylum, while bacterial community composition
and diversity seems to be independent of the reproductive
and metabolic abnormalities observed in these patients. Larger
studies with stratification of PCOS phenotypes are needed to
clarify the presence or absence of microbiome changes due to
different components of the syndrome. Bacterial functionality,
assessed by metagenomics and metatranscriptomics, can provide
further insights into the role of salivary bacteria in this condition.
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